Education
About Us
Working with TipRanks
Follow Us
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 164.07M | $ 1.19M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 40.08M | $ -9.57M | $ -21.14M | $ -13.98M | $ -8.71M |
| Operating Income | $ -395.28M | $ -460.56M | $ -398.88M | $ -342.70M | $ -261.94M |
| EBITDA | $ -395.28M | $ -427.43M | $ -374.76M | $ -328.27M | $ -250.87M |
| Net Income | $ -372.18M | $ -444.04M | $ -389.92M | $ -327.82M | $ -257.23M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 323.78M | $ 279.87M | $ 471.85M | $ 596.00M | $ 629.44M |
| Total Assets | $ 910.43M | $ 780.35M | $ 663.98M | $ 777.33M | $ 768.46M |
| Total Debt | $ 57.26M | $ 75.86M | $ 84.45M | $ 71.53M | $ 51.66M |
| Net Debt | $ -58.43M | $ -39.03M | $ -147.28M | $ -6.70M | $ -15.67M |
| Total Liabilities | $ 200.02M | $ 195.74M | $ 164.34M | $ 155.67M | $ 111.96M |
| Stockholders' Equity | $ 710.40M | $ 584.61M | $ 499.64M | $ 621.66M | $ 656.50M |
| Cash Flow | |||||
| Free Cash Flow | $ -364.05M | $ -384.11M | $ -313.18M | $ -265.51M | $ -251.93M |
| Operating Cash Flow | $ -352.98M | $ -361.82M | $ -292.76M | $ -227.94M | $ -205.13M |
| Investing Cash Flow | $ -96.41M | $ -155.24M | $ 256.45M | $ 132.00K | $ -317.85M |
| Financing Cash Flow | $ 390.66M | $ 462.96M | $ 190.15M | $ 239.27M | $ 576.42M |